Roundup Lawsuits

Thousands of people have filed lawsuits that blame Roundup for causing non-Hodgkin lymphoma and other related cancers. They say Roundup’s maker knew or should have known of the risks but failed to properly warn consumers.

“Bayer’s primary challenge in defending Roundup lawsuits lies in effectively addressing public perception and scientific evidence surrounding glyphosate’s safety,” Les Perlson, an employee benefits insurance agent with National Plan Administrators, told Drugwatch. “I’ve seen how regulatory pressures and public sentiment can drive legal outcomes and settlements, even in the absence of conclusive evidence.”

Despite settling around 100,000 claims for approximately $11 billion, Bayer still faces about 65,000 active lawsuits. Most of these are in state courts, but as of February 2026, 3,902 Roundup lawsuits were pending in a federal multidistrict litigation in a California federal court.

Throughout 2025, Bayer continued lobbying to influence legislation and protect itself from future lawsuits. Proposed legislation in Idaho that was meant to protect the manufacturer from future claims didn’t pass. The Iowa Senate passed a bill in 2024 to limit the lawsuits that could be brought against Bayer, but the Iowa House of Representatives did not take up the bill.

In February 2026, Bayer announced a settlement worth $7.25 billion to cover both current and future Roundup lawsuit claims. That settlement, which will need to be approved by a judge, could resolve tens of thousands of active cases.

No, the Roundup lawsuit is not a class action. These lawsuits are injury claims seeking compensation for non-Hodgkin lymphoma (and subtypes) after Roundup exposure. Some cases have been consolidated into multidistrict litigation (MDL), but each claim is still litigated separately.

Class action lawsuits consolidate multiple claims into one large case represented by the same lawyers, and they all get the same settlement or resolution. Roundup lawsuits in state courts or in the MDL are handled independently for each plaintiff. This allows for separate representation and individual settlement or jury assessments based on each case’s damages and merits.

In MDLs, both parties decide on bellwether trials. These are test trials that serve to evaluate how juries will view each case. Their outcomes often influence future trials and settlements in other MDL cases. If your Roundup lawsuit is filed in state court or the MDL, the time it takes to settle, the proof you need and the outcome of your case will vary depending on the facts of your case.

In February 2024, the 11th U.S. Circuit Court of Appeals refused to limit Bayer’s liability on Roundup lawsuits. The company argued that federal label requirements trumped state requirements to include a cancer warning. This makes it difficult for Bayer to fight these lawsuits and may increase pressure on the company to settle more suits.

In Roundup cases, “preemption” is the argument that federal pesticide law (FIFRA) and EPA‑approved labels override — or “preempt” — state failure‑to‑warn claims that say Monsanto should have added a cancer warning to Roundup’s label. Monsanto has argued that because EPA repeatedly approved Roundup labels without a cancer warning, any state‑law duty to add such cancer warnings is preempted by federal law.

Courts have been divided on preemption in Roundup litigation. The Supreme Court will now weigh in on the dispute and is expected to issue a decision by June 2026.

If you are interested in filing a Roundup lawsuit, it’s even more critical that you speak to an attorney right away to learn your legal options and preserve your right to file a claim.

In February 2026, Bayer announced a $7.25 billion settlement to resolve current and future Roundup claims. If approved, the settlement will likely resolve tens of thousands of lawsuits.

In March 2025, a Georgia jury awarded nearly $2.1 billion to a man who claimed he developed non-Hodgkin lymphoma after using Roundup for decades.

In October 2024, a Philadelphia jury handed out $78 million to William Melissen, who brought a lawsuit against Monsanto after being diagnosed with non-Hodgkin lymphoma in 2020.

In January 2024, a Philadelphia jury awarded a $2.25 billion Roundup lawsuit verdict to a Pennsylvania man who claimed Roundup caused his cancer. This verdict followed another Philadelphia jury’s $3.5 million verdict a month earlier.

Bayer agreed to pay $6.9 million to the state of New York to settle claims that the company misled consumers regarding Roundup’s environmental safety in June 2023. The funds will be used to mitigate the effects of pesticides on aquatic species and pollinators.

In May 2021, San Francisco U.S. District Judge Vince Chhabria denied Bayer’s offer of $2 billion to settle future claims, calling it “clearly unreasonable,” according to Reuters. Thousands of Roundup cancer claims remain pending in the California MDL and nationwide.

Bayer offered a $10.9 billion Roundup settlement to resolve about 100,000 Roundup cases in 2020.

Juries in California have awarded large verdicts to people who claimed Roundup causes cancer: $2 billion in May 2019, $80 million in March 2019 and $289 million in August 2018.

Roundup lawyers are still accepting claims to potentially go to trial or negotiate a settlement and the MDL remains open.

After you file a Roundup lawsuit, your case usually moves through a series of stages. However, the pace and outcome depend heavily on your evidence, the specific court handling your case and the damages you can prove.

Results in Roundup lawsuits are highly individualized. Whether a case settles, how long it takes and how much compensation is available all depend on the specific evidence of exposure and causation, the court and venue managing the case and the severity of medical and financial damages you can document.

Some cases may be resolved in one to three years, but a Roundup lawsuit can take several years.

People who developed non-Hodgkin lymphoma and related cancers after exposure to Roundup filed lawsuits against Monsanto and Bayer. Monsanto was acquired by Bayer in 2018.

The World Health Organization has classified glyphosate, the active ingredient in Roundup, as a probable human carcinogen.

“A common misconception is that the presence of glyphosate immediately equates to significant cancer risk,” Perlson said. ”Through my work with insurance plans, I’ve noted that public and media interpretations often leap to conclusions without thorough scientific vetting, contributing to widespread fear and legal pressure.”

Plaintiffs say the makers of Roundup didn’t warn the public about the cancer risks and engaged in tactics to deceive consumers about Roundup and the safety of its active ingredient, glyphosate.

People exposed to Roundup may file lawsuits to receive compensation for the extensive medical costs of treating cancer and their wish to provide for their family’s future. Compensation could include lost wages, loss of consortium, loss of future earnings and pain and suffering. Plaintiffs and their families also want to hold Bayer and Monsanto accountable for negligence.

Throughout the Roundup litigation, Monsanto’s internal corporate communications, dubbed the “Monsanto Papers,” revealed evidence that the company used deceptive tactics to suppress science and relationships with regulators to hide Roundup’s cancer links for years.

Monsanto and Bayer continue to support glyphosate’s safety, but based on evidence presented at trials, juries have awarded millions of dollars in punitive damages — funds awarded to punish defendants for especially negligent and harmful behavior.

The injuries named in Roundup cancer lawsuits center around non-Hodgkin lymphoma, a type of cancer originating in the white blood cells within the lymph nodes.

There are several types of related cancers that Roundup lawyers are accepting in lawsuits, some rarer than others. If you are unsure if your or a loved one’s type of cancer is included in lawsuits, contact a Roundup cancer lawyer for a free consultation.

Roundup’s link to cancer is controversial because the U.S. Environmental Protection Agency has said that “glyphosate is not likely to be carcinogenic to humans,” but the World Health Organization in 2015 said that the herbicide is “probably carcinogenic to humans.”

“There is an extensive body of research on glyphosate and Bayer’s glyphosate-based herbicides, including more than 800 studies submitted to the U.S. Environmental Protection Agency (EPA), in connection with the registration process, which confirms these products can be used safely and that glyphosate does not cause cancer,” says Bayer.

Critics say industry-funded research overwhelmingly shows Roundup doesn’t cause cancer, while non-industry studies link glyphosate to cancer and other health problems.

For example, an analysis published in Environmental Sciences Europe found that just 2% of industry-funded studies found a link between glyphosate and responses that could lead to cancer. In contrast, 67% of studies published in peer-reviewed journals found a link.

With the current evidence the EPA cites, glyphosate is not likely to be banned in the United States. Bayer announced it would stop selling glyphosate-based products on the U.S. residential market and come up with glyphosate alternatives. Their aim is “to help close the door on this litigation and ensure that any claims brought by individuals who use Roundup in the future are few and unlikely to succeed.

Bayer began producing the new formula in late 2022. While some of the old formulas may still be on store shelves, they are no longer being produced by the company, according to Bayer. If you are buying Roundup, make sure to read the product label to see if it contains glyphosate.

“There will be no change in the availability of the company’s glyphosate formulations in the U.S. professional and agricultural markets,” the company said.

You may qualify to file a Roundup cancer lawsuit if you were diagnosed with non-Hodgkin lymphoma or any of its subtypes after June 1, 2018. The reason is that there are statutes of limitations and time limits for lawsuits that start from the date of cancer diagnosis. Each state has its own rules that govern time limits, and you should check with a lawyer to see if you qualify, even if you think you don’t.

Depending on the state you live in, you may have as little as two years to file a claim. So, it’s important to seek legal representation right away. You are more likely to qualify for a Roundup lawsuit if you worked in commercial agriculture or landscaping because of the high exposure levels to Roundup.

Tell your attorney when your Roundup exposure began and how often you were exposed. Only a licensed Roundup lawyer can tell you if you qualify, and it doesn’t cost you anything to get a free consultation.

Roundup lawsuit filing deadlines are controlled by state statutes of limitations. These set a strict time window to sue after you are diagnosed with or reasonably discover that your cancer may be linked to Roundup. There are separate time limits for families bringing wrongful death claims.

In many Roundup cancer cases, the clock starts when you are first diagnosed with non‑Hodgkin lymphoma or when you find out your diagnosis could be linked to Roundup. Wrongful death statutes usually run from the date of death or from when the family learns the death may relate to Roundup. These deadlines are different in every state and can be short — often only one to three years — so waiting too long can stop you from filing or joining a settlement, even if your case would otherwise qualify.

Because there is no national deadline and some states use special rules for toxic‑exposure and cancer claims, it is critical to check your state’s rules rather than relying on general online timeframes. If you aren’t sure how this affects your case, make sure to talk to a lawyer.

You can prove your exposure by showing evidence that you encountered to Roundup at work, at home or on a farm. Types of evidence include purchase receipts, used Roundup bottles or landscaping invoices.

Your lawyer can also help you gather the necessary evidence. To support the injury side of a Roundup claim, people typically provide medical evidence like pathology reports, cancer diagnosis records, treatment summaries and other oncology records documenting non‑Hodgkin lymphoma and related care.

Following the June 2020 Roundup settlement where Bayer offered nearly $11 billion to resolve tens of thousands of Roundup cancer claims, lawyers estimated the average payout to be about $150,000 per plaintiff.

Bayer set aside an additional $1.25 billion to compensate future claimants. Depending on each claimant’s injuries and damages, lawyers estimate Roundup settlement amounts could be between $5,000 and $200,000 per person.

“Recent settlements without admission of liability suggest Bayer is prioritizing damage control and financial risk management over prolonged litigation,” Perlson said. “This strategy signals to the public a cautious acknowledgment of potential issues, potentially fostering a broader discussion on corporate transparency and accountability.”

Several case‑specific factors can raise or lower potential Roundup settlement amounts. They tend to be evaluated together rather than individually.

It’s important to note that publicized jury verdicts in Roundup trials can reach millions or even billions before reductions. However, these large awards are exceptional and often decreased on appeal.

Typical individual settlement ranges are more likely to fall in the low‑ to mid‑six figures for many cancer claims. Some cases with mild injuries may resolve for less.